Price Alert

Marinus Pharmaceuticals I... (MRNS)

NASDAQ: MRNS · Real-Time Price · USD

0.55

0.00 (0.00%)

At close: Feb 10, 2025, 3:59 PM

Marinus Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	42.18M	64.68M	104.25M	120.57M	140.44M	127.79M	146.9M	240.55M	168.25M	92.33M	126.32M	122.93M	145.1M	112.49M	123.47M
Short-Term Investments	n/a	n/a	9M	29.72M	35.92M	47.55M	52.3M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	1.34M	781K	839K	819K	1.86M	2.65M	23.58M	14.73M	2.31M	2.73M	2.75M	11.41M	2.73M	2.08M	2.17M
Receivables	3.84M	3.44M	3.51M	3.8M	4.28M	5.23M	11.69M	6.35M	3.4M	3M	2.49M	3.19M	3.53M	4.2M	2.65M
Inventory	6.72M	4.87M	5.78M	2.41M	2.74M	2.67M	37K	77K	104K	n/a	n/a	-557K	n/a	n/a	n/a
Other Current Assets	4.66M	8.9M	8.73M	8.75M	11.67M	11.37M	9.06M	5.4M	5.25M	5.76M	6.26M	n/a	n/a	n/a	n/a
Total Current Assets	57.4M	81.88M	131.28M	165.25M	195.04M	194.61M	199.2M	240.55M	177.01M	101.09M	135.07M	122.93M	153.49M	120.92M	129.8M
Property-Plant & Equipment	4.88M	4.42M	5.24M	4.84M	3.91M	3.94M	4.04M	4.24M	5.52M	5.56M	2.99M	2.5M	2.65M	1.98M	1.89M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	6.22M	5.2M	6.07M	5.66M	5.77M	6.59M	27.62M	18.97M	7.83M	8.29M	5.74M	13.91M	5.38M	4.07M	4.06M
Total Assets	63.62M	87.08M	137.35M	170.91M	200.81M	201.2M	226.82M	259.52M	184.84M	109.38M	140.81M	136.84M	158.87M	124.99M	133.86M
Account Payables	3.71M	6.24M	6.13M	4M	2.63M	2.3M	4.47M	4.46M	1.62M	3.3M	4.67M	3.13M	693K	3.31M	5.17M
Deferred Revenue	n/a	n/a	n/a	n/a	17.62M	-681K	n/a	n/a	-1.82M	-595K	n/a	15.65M	14.62M	n/a	n/a
Short-Term Debt	13.47M	11.55M	15.4M	13.76M	7.7M	3.85M	1.32M	1.02M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	n/a	n/a	n/a	-2.21M	n/a	13.27M	11.61M	2.44M	10.59M	n/a	n/a	21.23M	21.83M	n/a	n/a
Total Current Liabilities	34.5M	35.87M	42.76M	40.62M	30.55M	25.6M	21.51M	54.87M	21.05M	23.11M	19.54M	40.57M	37.68M	16.69M	16.12M
Long-Term Debt	41.71M	80.51M	92.71M	95.19M	64.78M	68.14M	102.39M	71.02M	70.78M	70.35M	69.93M	40.81M	40.58M	10.97M	n/a
Other Long-Term Liabilities	18.11M	n/a	n/a	152K	32.85M	31.95M	n/a	29.86M	n/a	n/a	n/a	n/a	2.12M	2.27M	n/a
Total Long-Term Liabilities	95.86M	98.56M	111.03M	113.52M	115.71M	118.26M	120.22M	88.64M	81.79M	81.46M	80.87M	42.79M	42.7M	13.24M	2.4M
Total Liabilities	130.36M	134.43M	153.78M	154.14M	146.27M	143.86M	141.73M	143.52M	102.84M	104.57M	100.41M	83.35M	80.38M	29.93M	18.52M
Total Debt	55.99M	95.89M	112.51M	110.36M	74.16M	105.77M	102.39M	72.67M	72.9M	72.62M	72.33M	40.81M	41.12M	11.5M	2.92M
Book Value	-66.74M	-47.34M	-16.43M	16.77M	54.54M	57.34M	85.08M	116M	82M	4.8M	40.41M	53.49M	78.49M	95.06M	115.33M
Book Value Per Share	-1.17	-0.83	-0.29	0.30	1.01	1.09	1.64	2.58	2.20	0.13	1.10	1.46	2.14	2.59	3.15
Common Stock	55K	55K	55K	55K	55K	51K	50K	50K	37K	37K	37K	37K	37K	37K	37K
Retained Earnings	-670.65M	-646.42M	-610.6M	-571.93M	-530.16M	-497.19M	-465.25M	-430.52M	-396.21M	-469.5M	-430.07M	-410.7M	-382.4M	-362.89M	-339.07M
Comprehensive Income	n/a	n/a	n/a	-20K	-71K	-114K	74K	n/a	n/a	0.00	-0.00	-4.3M	-0.00	-0.00	-0.00
Shareholders Equity	-66.74M	-47.34M	-16.43M	16.77M	54.54M	57.34M	85.08M	116M	82M	4.8M	40.41M	53.49M	78.49M	95.06M	115.33M
Total Investments	n/a	n/a	9M	29.72M	35.92M	47.55M	52.3M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a